MedTrace Logo

Using Re-inforcement Learning to Automatically Adapt a Remote Therapy Intervention (RTI) for Reducing Adolescent Violence Involvement

NCT04850274 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 584

Last updated 2026-05-06

No results posted yet for this study

Summary

This study will use a randomized control trial (RCT) design to administer two versions of a multisession remote behavioral intervention for youth seeking Emergency Department care for a violent injury with the goal to reduce their violence involvement and associated negative behaviors and consequences. The study examines two versions of the remote therapy intervention - a standard RTI (S-RTI) and an Artificial Intelligence RTI (AI-RTI). The application of a just-in-time adaptive strategy to address youth violence is an important and novel direction for this research, particularly given the need to understand best practices for delivering behavioral interventions among lower-income populations.

Conditions

  • Violence
  • Substance Use
  • Criminal Behavior
  • Violence in Adolescence

Interventions

BEHAVIORAL

Remote Therapy Intervention (RTI)

A single ED session followed by 5 remote therapy sessions

BEHAVIORAL

Artificial Intelligence Remote Therapy Intervention

Optimized by reinforcement learning to step up or down the intensity of treatment between three levels based on patient response to daily assessments.

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • University of Michigan

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
24 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-19
Primary Completion
2026-02-13
Completion
2026-02-13

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04850274 on ClinicalTrials.gov